Day: June 14, 2018

Achievement of pre-clinical milestone triggers $4M payment from GSK to Epizyme Epizyme.

For each target in the collaboration, Epizyme will lead to research up to advancement candidate selection primarily, and GSK will be responsible for advancement and commercialization solely.. Achievement of pre-clinical milestone triggers $4M payment from GSK to Epizyme Epizyme, Inc., a company leading the discovery and development of customized therapeutics for genetically-described cancer patients, today announced the achievement of pre-scientific milestones in it is alliance with GlaxoSmithKline , triggering $4 million in milestone payments. Read More